Bradykinin receptor B1 (BDKRB1), an inflammation-inducible G protein-coupled receptor, has been implicated in tumor-associated inflammatory signaling; however, its genomic determinants and immunological relevance in ovarian cancer remain poorly defined.<h4>Methods</h4>We performed an integrative multiomics analysis of BDKRB1 using TCGA-OV and multiple independent GEO cohorts. Here, BDKRB1 is linked to ovarian carcinoma.